Helsinn Healthcare S.A.: Helsinn to present data at upcoming

Helsinn to present data at upcoming AMMF's 2022 European Cholangiocarcinoma Conference Lugano, Switzerland, May 11, 2022 - Helsinn Group ("Helsinn"), a fully integrated, global biopharma company

Related Keywords

China , Lugano , Ticino , Switzerland , Ireland , United Kingdom , Essex , Kostenloser Wertpapierhandel , Paola Bonvicini , Angela Lamarca , Giorgio Calderari , Gastroenterol Hepatol , United Kingdom Cholangiocarcinoma Charity , Linkedin , European Network For The Study Of Cholangiocarcinoma , Twitter , Radisson Blu Hotel , Helsinn Group , Helsinn Birex Pharmaceuticals Ltd , Group Head Of Communication , Alan Morement Memorial Fund , Co Glob Oncol , Stansted Airport , Kingdom Cholangiocarcinoma , Fully Integrated Targeted Therapy , Medical Oncologist , Helsinn Birex Pharmaceuticals , Genomic Analysis , Cholangiocarcinoma Identifies Distinct , Mutant Molecular , Cell Rep , Quan Lim , Endemic Fluke Associated , European Network , Rev Gastroenterol Hepatol , Media Contact , Helsinn , Healthcare , Present , Data , Pcoming , Wmmf , 022 , European , Cholangiocarcinoma , Conference ,